Search from website
Search from website
Figure 1. Coomassie-stained SDS-PAGE analysis of monoclonal antibody to SARS-CoV-2 Spike RBD, clone 30C5. 4-12% gradient gel is used for analysis. Lane 1. Monoclonal antibody to SARS-CoV-2 Spike RBD, clone 30C5(-DTT). Lane 2. Size marker. Lane 3. Monoclonal antibody to SARS-CoV-2 Spike RBD, clone 30C5 (+DTT). Lane 4. Size marker.
Figure 2. HPLC analytical SEC for final product.
Figure 3. HPLC analytical SEC after 3 freeze-thaw cycles.
Catalogue #
R1-161-100
Name
Human IgG1-kappa antibody to SARS CoV-2 S1 RBD (clone 30C5)
Target
SARS-CoV-2 virus
Target Description
SARS-CoV-2 virus (PBMCs isolated from patients recovered from SARS-CoV-2 infection, antibodies discovered by using HybriFree Technology).
Clonality
Human monoclonal
Clone
30C5
Class
hIgG1
Reactivity
SARS-CoV-2 Spike RBD
Dissociation constant (KD)
2.63 x 10-10 M (measured against SARS-CoV-2 Trimeric Spike protein)
8.6 x 10-8 M (measured against SARS-CoV-2 Spike S1 protein)
Application
ELISA
ELISA:
indirect ELISA 0,08-0,16 ng/ml
Purification
Protein A affinity chromatography following desalting
Buffer
PBS pH 7.4
Shipping
Shipped at ambient temperature.
Storage
Store at +4 °C. Avoid multiple freeze-thaw cycles.
This product is for research use only
TECHNICAL ASSISTANCE
Please refer any technical questions to
technical.support@icosagen.com
© 2025 Icosagen
